Professor Anthony Harnden has been appointed as the new Chair of the Medicine and Healthcare products Regulatory Agency (MHRA).
Anthony is a Professor of Primary Care in the Nuffield Department of Primary Care Health Sciences at the University of Oxford, having first joined the department in 1992. Until the end of December 2024, he is a registrant Council member of the General Medical Council and Chair of the Renumeration Committee. Anthony was a General Practitioner for 33 years in Wheatley, Oxfordshire and worked for the NHS for 40 years. He was also previously Deputy Chair of the Joint Committee on Vaccination and Immunisation (JCVI) and played a key role in ensuring public trust and patient safety during the distribution of the Covid vaccine.
He succeeds former MHRA chair Stephen Lightfoot, who served from September 2020 and stepped down in 2023.
The chair will play a key role in driving forward the strategic direction of MHRA to maintain the UK as a global centre of excellence in life sciences, in the best interests of patients and the public.
Health Minister, Karin Smyth, said:
‘I am delighted to welcome Anthony, who brings a wealth of regulatory and healthcare experience. The MHRA plays a vital role in ensuring the safe use of medicines, medical devices and blood transfusions across the UK and I look forward to working with Anthony as we reform our health service and make it fit for the future.’
Read the full story on the the Nuffield Department of Primary Care Health Sciences website.
more recommended stories
Rapid-Acting Antidepressants Share Neuroimmune PathwaysKey Points Researchers identified common neuroimmune.
SuperAgers and Alzheimer’s Disease Risk ExplainedKey Summary SuperAgers maintain exceptional episodic.
Inherited Genetics and Cancer Susceptibility ExplainedKey Summary Inherited genetics directly influences.
Multiple Sclerosis Mortality Trends Reveal Care Gaps in the USAKey Points Multiple sclerosis mortality in.
Drinking Water With Meals Linked to Higher Food IntakeKey Points Summary A new Appetite.
Cyclosporiasis Risk: Who Faces the Highest Threat?Key Summary Cyclosporiasis cases are increasing.
EP2 Receptor Research Opens New Path for Healthy AgingKey Points Researchers identified the EP2.
Obesity-Associated Leukemia Linked to InflammationKey Takeaways Researchers identified how obesity.
Chronic Xanthan Gum Alters Gut Microbiota and Colon HealthKey Points Chronic xanthan gum consumption.
Calcific Aortic Valve Stenosis Linked to Gum Disease BacteriaKey Points Researchers identified a potential.
Leave a Comment